A STABLE PHARMACEUTICAL FORMULATION OF PAROXETINE HYDROCHLORIDE AND A PROCESS FOR PREPARATION THEREOF

Title:

A STABLE PHARMACEUTICAL FORMULATION OF PAROXETINE HYDROCHLORIDE AND A PROCESS FOR PREPARATION THEREOF

Document Type and Number:

WIPO Patent Application WO2003057150

Kind Code:

A3

Abstract:

Provided are formulations of a stable paroxetine hydrochloride tablet comprising paroxetine hydrochloride, povidone or copovidone as a binder, and an HCl free/non-hygroscopic filler, prepared by the wet granulation method. Preferably, the paroxetine hydrochloride is paroxetine hydrochloride hemihydrate.

More Like This:

JP5752601	Composition of protein receptor tyrosine kinase inhibitor
JP4143705	Manufacturing method of drug release material
JP2010285445	NO-RELEASING NSAID ADSORBED TO CARRIER PARTICLE

Inventors:

FOX MICHAEL (IL)
COHEN RAKEFET (IL)
BRAUNSTEIN ANNE (IL)
LEIBOVICI MINUTZA (IL)

Application Number:

PCT/US2002/041429

Publication Date:

June 08, 2006

Filing Date:

December 27, 2002

Export Citation:

Click for automatic bibliography generation Help

Assignee:

TEVA PHARMA (US)
TEVA PHARMA (US)
FOX MICHAEL (IL)
COHEN RAKEFET (IL)
BRAUNSTEIN ANNE (IL)
LEIBOVICI MINUTZA (IL)

International Classes:

A61K9/14; A61K9/20; A61K9/26; A61K9/28; A61K9/40; A61K9/46; A61K9/48; A61K31/4525

Foreign References:

US6168805B1

2001-01-02

Download PDF:

View/Download PDF PDF Help

Previous Patent: 4-SUBSTITUTED FUSED HETEROPYRIMIDINES AND FUSED HETERO-4-PYRIMIDONES

Next Patent: A STABLE PHARMACEUTICAL FORMULATION OF PAROXETINE HYDROCHLORIDE ANHYDROUS AND A PROCESS FOR PREPARAT...